1
Jason M Vaughn, Justin R Hughey, Tanesha Roberts, Tatyana Dyakonov, Sunil Agnihotri, Aqeel A Fatmi: Fumarate ester dosage forms. BANNER LIFE SCIENCES, Brinks Gilson & Lione, May 2, 2017: US09636319

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One e ...


2
Jason M Vaughn, Justin R Hughey, Tanesha Roberts, Tatyana Dyakonov, Sunil Agnihotri, Aqeel A Fatmi: Fumarate ester dosage forms. BANNER LIFE SCIENCES, Brinks Gilson & Lione, February 14, 2017: US09566259

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One e ...


3
Jason M Vaughn, Justin R Hughey, Tanesha Roberts, Tatyana Dyakonov, Sunil Agnihotri, Aqeel A Fatmi: Fumarate ester dosage forms. BANNER LIFE SCIENCES, Brinks Gilson & Lione, May 2, 2017: US09636318

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One e ...


4
FUMARATE ESTER DOSAGE FORMS. March 2, 2017: US20170056360-A1

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One e ...


5
FUMARATE ESTER DOSAGE FORMS. March 2, 2017: US20170056359-A1

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One e ...


6
FUMARATE ESTER DOSAGE FORMS. April 13, 2017: US20170100361-A1

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One e ...


7
FUMARATE ESTER DOSAGE FORMS. April 13, 2017: US20170100362-A1

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One e ...


8
FUMARATE ESTER DOSAGE FORMS. August 17, 2017: US20170231942-A1

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One e ...



Click the thumbnails below to visualize the patent trend.